Literature DB >> 22830615

Low incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China.

Yi Pan1, Bin Meng, Huilai Zhang, Wenfeng Cao, Huaqing Wang, Chengfeng Bi, Fujin Liu, Baocun Sun, Xishan Hao, Weiyun Z Ai, Kai Fu.   

Abstract

The purpose of this study was to examine the incidence of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma of the elderly in a representative northern Chinese population. Overall, 212 cases of primary diffuse large B-cell lymphoma were analyzed for EBV-positive status by detection of EBV-encoded RNA using in situ hybridization. Immunophenotypic identity was verified by a streptavidin-biotin peroxidase detection system using the markers CD20, CD3, CD10, BCL6 and MUM1. The prevalence of EBV-positive diffuse large B-cell lymphoma in elderly northern Chinese patients was 3.8% (eight of 212). All eight cases were negative for CD10 and BCL6 immunostaining. The incidence is less frequent than that of southern China and other East-Asian countries. Patients tend to be older, present with a non-germinal center B-cell-like immunophenotype and have a poor outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22830615     DOI: 10.3109/10428194.2012.715347

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

Review 1.  EBV-positive diffuse large B-cell lymphoma of the elderly.

Authors:  Chi Young Ok; Thomas G Papathomas; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

2.  Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.

Authors:  Akinao Okamoto; Masamitsu Yanada; Hiroki Miura; Yoko Inaguma; Masutaka Tokuda; Satoko Morishima; Tadaharu Kanie; Yukiya Yamamoto; Shuichi Mizuta; Yoshiki Akatsuka; Tetsushi Yoshikawa; Yoshikazu Mizoguchi; Shigeo Nakamura; Masataka Okamoto; Nobuhiko Emi
Journal:  Cancer Sci       Date:  2015-10-07       Impact factor: 6.716

Review 3.  Estimating the global burden of Epstein-Barr virus-related cancers.

Authors:  Yide Wong; Michael T Meehan; Scott R Burrows; Denise L Doolan; John J Miles
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-27       Impact factor: 4.553

4.  Association of Human Papillomavirus and Epstein-Barr Virus Infection with Tonsil Cancer in Northeastern Thailand.

Authors:  Chukkris Heawchaiyaphum; Tipaya Ekalaksananan; Natcha Patarapadungkit; Patravoot Vatanasapt; Chamsai Pientong
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

5.  An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers.

Authors:  Shin-Ichi Nakatsuka; Chikao Yutani; Masako Kurashige; Masaharu Kohara; Teruaki Nagano; Takayoshi Goto; Hiroyuki Takatsuka; Hidetaka Ifuku; Eiichi Morii
Journal:  Diagn Pathol       Date:  2017-01-31       Impact factor: 2.644

Review 6.  Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma.

Authors:  Paola Chabay
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

7.  New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis.

Authors:  Ana Banko; Danijela Miljanovic; Ivana Lazarevic; Ivica Jeremic; Aleksa Despotovic; Milka Grk; Andja Cirkovic
Journal:  Viruses       Date:  2022-01-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.